Novartis using Emisphere technology in tests
-
- June
- 30
Emisphere Technologies Inc., the biopharmaceutical company with research and development operations in Eastview, said this morning that Novartis Pharma AG has launched a study to determine whether a drug is effective in treating osteoporosis in women who are past menopause. Novartis will test oral PTH134 using Emisphere’s Eligen technology. The testing is being done in Switzerland.
This entry was posted
on Monday, June 30th, 2008 at 9:31 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
Advertisement
